% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internation Message Board

rick3568 11 posts  |  Last Activity: Jun 27, 2015 5:02 PM Member since: Jun 24, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    A Big Surprise for the Shorts?

    by repo_man_one Jun 26, 2015 8:52 PM
    rick3568 rick3568 Jun 27, 2015 5:02 PM Flag

    Oh, is that why the stock is dropping.

  • Reply to

    How Much Knowledge

    by repo_man_one Jun 1, 2015 11:13 AM
    rick3568 rick3568 Jun 3, 2015 4:18 PM Flag

    Hey Franco/Phrma, hows life in the welfare line?

  • Reply to

    How Much Knowledge

    by repo_man_one Jun 1, 2015 11:13 AM
    rick3568 rick3568 Jun 3, 2015 10:36 AM Flag

    Um, yeah. It isnt an "accident". But it is not necessarily a big deal either. It certainly does not mean a big announcement is imminent, as you are insinuating.

    They are at the same address because RCPI consolidated management, remember? Its a cost savings measure. It makes sense. Mullan runs Roskamp. SRQBio, LLC is a wholly owned subsidiary OF Roskamp. So yeah the work together. Crawford is part of SRQBio.

    We know already that Roskamp and RCPI have been "partners". And what has the PPS done since their partnership? Lost about 97% from the highs.

    So this is a pointless discussion - just more pump. Hopefully there is big news, but this is certainly not part of it.

  • Reply to

    here's our beloved drummword

    by remytuckkeating May 21, 2015 10:02 AM
    rick3568 rick3568 May 21, 2015 10:43 AM Flag

    Heres the fully thing. Since this post in Nov 2011, RMBS is a triple from the lows. And really a solid double.

    RCPI? Well in the same timeframe its approx a 97% loss.


  • Reply to

    I have a question

    by francogarabaldi May 16, 2015 11:28 AM
    rick3568 rick3568 May 18, 2015 1:18 AM Flag

    Either does RCPI.

    Racist Franco/Pharma, I love the fact that youre broke on this stock. That you feel the need to mindlessly post day after day with 15 different handles trying to pump away on this stock.
    Then with one fact filled post, a rational investor can outdo any nonsense you can conjure up.
    Your only weapon, distract and deflect with politics, racism, etc.
    Your BS is as transparent as your savings account.

    Sentiment: Strong Sell

  • Reply to

    I have a question

    by francogarabaldi May 16, 2015 11:28 AM
    rick3568 rick3568 May 16, 2015 10:48 PM Flag

    I have an answer thats funnier. All the cash you have lost! LOL!
    If you spent half the time thinking about who I vote for than you do about your stocks, well, you know.

    I realize you are always so interested in me, but how many times do I have to tell you, Im straight. All this attention seeking wont work. Good news though, when a Democrat makes it into the White house again, Im sure the stock market will triple once more and marriage equality will stay the law of the land. Still it sadly wont help RCPI.

  • rick3568 rick3568 May 13, 2015 7:44 PM Flag

    Even if this is the case, HOW does this change your situation?
    How does blaming shorts make you money?
    If that worked, every fact-challenged long here would be a millionaire by now.

  • Reply to

    And another basher says

    by repo_man_one May 13, 2015 12:04 PM
    rick3568 rick3568 May 13, 2015 3:19 PM Flag

    Good point yes.
    I dont get why anyone would put hard earned cash into this, other than a short term swing. Why not wait until the picture is clearer? The risks far outweigh the rewards at this juncture, and they have for a long while. Turns out that strategy WAS the right one.
    I mean who cares what the purpose of an overseas phase 1 trial is when your cash runs out in days or weeks? Sometimes the best thing you can do is sit and wait.

  • Reply to

    And another basher says

    by repo_man_one May 13, 2015 12:04 PM
    rick3568 rick3568 May 13, 2015 1:01 PM Flag

    100% agreement. Product worked for me, and I find it unlikely shareholders of RCPI will benefit from any breakthroughs down the road.

    One simply has to read the latest 10-q to see why.

    Money runs out in June. More dilution will be needed. The company has not been profitable in 12 years, and is many many years from being profitable again. This assumes, of course things go perfectly with studies, which is no guarantee.

    And my personal favorite, JW emailing the company in March saying he is due a severance package. For what ??!! Scandals, ruining shareholder value, nepotism and many years of million dollar salaries despite 12 years of losses. Again, JW could make a welfare queen blush.

    When there is another dilution, if its major or negative headline hit, its possible the stock could slip below $1 a share again even after the split.

    Again the shame of it all is I do believe they have "something". I personally loved the product. Unfortunately management greed and entitlement got in the way IMO.

  • Reply to


    by norbertdt May 7, 2015 2:48 PM
    rick3568 rick3568 May 8, 2015 9:29 AM Flag

    None of what you said surprises me. I loved the product. It was the management and the way the company was run that I couldnt stand anymore. Talk about putting the cart before the horse, management paid themselves before success all on the backs of shareholders. Since where is that Entrepreneurial? Thats corporate welfare and entitlement, not capitalism.

    Its my hope that some other firm takes over the patents or the ideas and runs with it in supplement form. Otherwise even if by some miracle this is FDA approved, it will likely be 7 years or more before anyone can use it.

  • rick3568 rick3568 Apr 30, 2015 12:46 PM Flag

    Yep. its why I got out. Despite the fact that the product worked for me, I knew that Pharma is a long road. I always thought there could be hope with the supplement, however "hockey stick" growth in revenue failed to materialize. Then once the product was gone, that was is it. There is no real patent protection at this point (JW has many of those that do exist), the cash situation is abysmal and the data trials are far too early. Who needs shorts with all that, especially considering the value is still in the multi millions of dollar range. Still room to drop if there are setbacks, and a slow bleed is also possible if no real positive stories develop and there is a new vacuum.